In 2022, ARI awarded more more than $450,000 in grants to fund innovative research that holds realistic promise in impacting the lives of autistic people. In order to provide parents and professionals with an independent, unbiased assessment of causal and treatment efficacy issues, ARI seeks no financial support from government agencies or drug manufacturers.
More Research Studies
2022
miRNA as a potential mediator in maternal/fetal interaction in neurodevelopmental disorders
David Beversdorf, MD
University of Missouri
Impact of environmental enrichment on the resolution of inflammation in a mouse model of Autism Spectrum Disorder
Paola Bonsi, PhD
Fondazione Santa Lucia
Understanding Role of Peroxynitrite Signaling and Developing Therapeutic Intervention for Autism Spectrum Disorder
Adrien Eshraghi, MD, MSc, FACS
University of Miami Hearing Research and Communication Laboratory
Placental Trophoblast Inclusions as Autism Risk Markers Among Preterm Infants
Morgan Firestein, PhD
Columbia University Irving Medical Center
Zinc nutrition as key regulator of inflammatory gut-brain signaling in Autism
Andreas Grabrucker, PhD
University of Limerick
Discovery of ASD related pathways in a novel preterm Rhesus macaque maternal immune activation model
Suhas Kallapur, MD
University of California Los Angeles
Rescue of a neurodevelopmental disorder associated with ASD by induction of the heat shock response
Andrew Levy, PhD
Technion Israel Institute of Technology
Characterizing Auditory Sensory Stability in Autism
Adam Naples, PhD
Yale University
Testing cannabinoid type 2 receptor (CB2R) as a potential therapeutic target in ASD: a pilot study on a mouse model of maternal immune activation
Anna Maria Tartaglione, PhD
Istituto Superiore di Sanità (ISS), Italy
Home-based measurement of autonomic and endocrine system function and relations to sensory processing in children with and without autism
Jennifer Wagner, PhD
CUNY College of Staten Island
Is there a relationship between the gut mucosal-associated microbiome, intestinal neurotransmitters and behavior in individuals on the autism spectrum?
Harland Winter, MD
Massachusetts General Hospital